Cart
sales@molnova.com
Protosappanin B
CAS No. 102036-29-3
Protosappanin B( (-)-Protosappanin B )
Catalog No. M17754 CAS No. 102036-29-3
Protosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 73 | In Stock |
|
| 5MG | 64 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 185 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProtosappanin B
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43.
-
DescriptionProtosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43. Protosappanin B induces the degradation of p53 protein, via activation of a MDM2-dependent ubiquitination process.
-
In VitroProtosappanin B (12.5, 25, 50, 100, 200 μg/mL, 48 hours) dose-dependently inhibits tumor cells, with IC50s of 21.32 μg/mL, 26.73 μg/mL, and 76.53 μg/mL for SW-480, HCT-116, and BTT cells, respectively. Cell Viability Assay Cell Line:CT-116, SW-480, and BTT Cells Concentration:12.5, 25, 50, 100, 200 μg/mL Incubation Time:48 hours Result:Dose-dependently inhibited tumor cells after 48 hours of treatment.
-
In Vivo——
-
Synonyms(-)-Protosappanin B
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number102036-29-3
-
Formula Weight304.29
-
Molecular FormulaC16H16O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (164.32 mM)
-
SMILESC1C2=CC(=C(C=C2C3=C(C=C(C=C3)O)OCC1(CO)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Beta-Hederin
Beta-Hederin has apoptotic effect on breast cancer cells, it could be a promising candidate for chemotherapy of breast cancer.
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
-
Topilutamide
Topilutamide is a topical nonsteroidal antiandrogen.
